Status:

ACTIVE_NOT_RECRUITING

S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

Lead Sponsor:

Medical University of Warsaw

Collaborating Sponsors:

National Science Centre, Poland

Conditions:

Primary Sclerosing Cholangitis (PSC)

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The aim of this study is to investigate clinical effects (liver biochemistries, health-related quality of life, liver stiffness) and underlying mechanisms of hepatoprotection of S-adenosylmethionine i...

Detailed Description

The study is designed as a randomised, double-blind, placebo-controlled trial. Eighty participants will be randomized in 1:1 ratio to one of two arms of the study: Intervention or Placebo. Participan...

Eligibility Criteria

Inclusion

  • primary sclerosing cholangitis fulfilling EASL criteria;
  • age: 18 - 75 years;
  • treatment with ursodeoxycholic acid (UDCA) in a dose of 13-15mg/kg b.w. for at least 6 months.

Exclusion

  • inability to give informed consent;
  • patients with other forms of chronic liver diseases;
  • decompensated liver cirrhosis (Child-Pugh class B-C);
  • patients with PSC who underwent stenting of their biliary tree within 6 months;
  • other diseases or states that can affect quality of life and mood: decompensated diabetes mellitus, renal insufficiency requiring dialyses, malignancy, heart failure ≥ New York Heart Association (NYHA) II, organ transplantation, known HIV infection, rheumatoid arthritis, asthma, psychiatric disorders;
  • treatment with: steroids, statins, rifampicin, antidepressants;
  • pregnant or breastfeeding women;
  • history of hypersensitivity reactions to S-adenosylmethionine;
  • any other condition, which in the opinion of the investigators would impede the patient's participation or compliance in the study.

Key Trial Info

Start Date :

August 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06026865

Start Date

August 1 2023

End Date

June 1 2026

Last Update

April 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Hepatology, Transplantology and Internal Medicine, Medical University of Warsaw

Warsaw, Poland

S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC) | DecenTrialz